WHWK Whitehawk Therapeutics Inc
Healthcare$4.49+4.42%ClosedMarket Cap: $222.0M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.68
P/S
0.00
EV/EBITDA
-1.58
DCF Value
$-4.61
FCF Yield
-44.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-79.6%
ROA
-91.0%
ROIC
-105.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-23.5M | $-22.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-24.9M | $-23.3M | $— | — |
| FY null | $7.1M | 89.4% | $-114.4M | $-20.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-19.5M | $-17.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-54.7M | $-52.6M | $— | — |
| Q1 null | $7.1M | 89.4% | $-15.2M | $73.0M | $— | — |
| Q4 null | $7.2M | -109.1% | $-18.9M | $-18.3M | $— | — |
| FY null | $26.0M | -108.0% | $-67.5M | $-63.7M | $— | — |
| Q3 null | $7.2M | -49.8% | $-13.4M | $-12.5M | $— | — |
| Q2 null | $6.2M | -124.5% | $-15.6M | $-14.6M | $— | — |
| Q1 null | $5.4M | -166.1% | $-19.5M | $-18.3M | $— | — |
| Q4 2023 | $6.3M | -116.5% | $-17.7M | $-16.3M | $-0.60 | — |